⚠️ Not investment advice. This is a quantitative research tool; every decision is the user's own responsibility. Past performance does not guarantee future results.⚠️ Not investment advice. Past performance does not guarantee future results.
⚠️ Not investment advice. Past performance does not guarantee future results.
🔓 Free accountRanking, alerts and Top 10Sign up with GoogleSign in

Core Scientific CORZ

United StatesTechnology · Software - InfrastructureUSD
4.8AI score
Rank 1,778 of 2,130
better than 16% of companies
15.94USD
▼ 13.9% in one year
CORZ MSCI World +22.1%
Average analyst target
33.05 USD (+107.3%)
21 analysts
52-wk low 13.36High 30.46
📈 Chart on TradingView ↗(affiliate link)Analysis of 08/10/2026

What does it do?

Core Scientific is a digital infrastructure company that operates high-performance data centers, primarily for cryptocurrency (Bitcoin) mining and, increasingly, for hosting AI and HPC computing.

Key points

from its scores
  • ✓Strong growth10.0
  • ✕Unfavourable risk and backdrop0.3
  • ✕Little or no dividend1.5
  • ✕Demanding valuation3.9

AI analysis

bottom line, main risk, context and news
Bottom line

Hold in the portfolio only for high-risk profiles that believe in the long-term growth thesis of AI and Bitcoin; the current multiple already discounts much of the future success.

Core Scientific shows explosive revenue growth of 108.8% and a very strong net cash position (Net Debt/EBITDA of -33.71), but its valuation is extremely demanding (forward P/E of 97.94) and its operating margin is low (6.87%), reflecting a rapidly expanding business with profitability still to consolidate.

⚠ Main risk

Dependence on the price of Bitcoin and on demand for AI compute capacity makes its profitability and valuation extremely sensitive to a shift in market sentiment or a decline in demand for data centers.

Context and risks

No recent news and no material exposure to current macro factors: the rise in long-term rates and dollar strength do not directly affect a cloud computing and cryptocurrency mining infrastructure business, which does not depend on commodities or shipping routes. The main risk is operational and business model related, not macro.

Is Core Scientific stock cheap or expensive?

at the analysis date
Pricier than its sector

On Price / sales, it trades 120% above the Technology median.

MultipleCompanySectorDifference
Price / sales11.65.3+120%

Sector: median of the 283 Technology companies analysed. In bold, the multiples used for the comparison.

Valuation score: 3.9 out of 10 (median for Technology: 5.3).

Average analyst target: 33.05 USD, +107.3% versus the price.

A premium can be justified if the company is of higher quality or grows faster than its sector: Quality / Moat 4.7 (sector 6.4), Growth 10.0 (sector 7.5).

Indicative fair value · USD
Cash flow (DCF)25.46▲ +60% vs price
Price15.94at the analysis date

Classic formulas with standard assumptions (5.0% growth, 8-9% discount rate). Indicative only: they change a lot with the assumptions and are not a recommendation.

Work out its fair value yourself →How much would you have made investing every month? →

Comparing it with its sector does not say whether it is a good buy: this is not investment advice.

🛒 Where to buy CORZCheapest · US (NYSE/Nasdaq) · sample 200.00 € orderCheapest · US (NYSE/Nasdaq) · sample 200.00 € orderAvailable in your country · US (NYSE/Nasdaq) · sample 200.00 € order
By the cost of that order: commission and FX, taxes excluded (public fee schedules). Brokers marked «affiliate» may pay Meridian a commission at no cost to you. This is not investment advice. · Compare all 22 brokers by real cost →

Score by category

0 to 10 · hover overtap each one to see what it measures
Financial healthiFair6.4Technology median: 6.9
Quality / MoatiWeak4.7Technology median: 6.4
ValuationiWeak3.9Technology median: 5.3
GrowthiExcellent10.0Technology median: 7.5
DividendiPoor1.5Technology median: 1.5
MomentumiWeak3.9Technology median: 6.3
Risk & ContextiPoor0.3Technology median: 4.8
Technology median7 or more 5 to 7 under 5

Key metrics

at the analysis date · compared with the Technology median
EV / EBITDAi
−99.2
Technology: 20.4below
Operating margini
6.9%
Technology: 15.5%below
Net debt / EBITDAi
−33.71
Technology: 0.20net cash
Revenue growthi
+108.8%
Technology: +16.7%above
Dividend yieldi
0.0%
Technology: 0.0%in line
Forward P/Ei
97.9
Technology: 20.3above

Valuation

Forward P/E
97.9
EV / EBITDA
−99.2
Price / book
−2.1
Price / sales
11.6
Market cap
5.1B USD
Enterprise value
7.8B USD

Profitability

ROA
−2.4%
Gross margin
32.1%
Operating margin
6.9%
Net margin
0.0%
Free cash flow
464.8M USD
FCF yield
9.1%

Solvency

Total debt
4.4B USD
Net debt
2.6B USD
Cash
1.8B USD
EBITDA
−78.2M USD
Net debt / EBITDA
−33.71
Current ratio
0.89
Quick ratio
0.65

Growth

Revenue growth
+108.8%
EPS (TTM)
−4.25 USD
EPS (forward)
0.16 USD

Dividend

Dividend yield
0.0%
Payout
0.0%

Risk and market

Beta
5.48
Analyst consensus
Strong buy (21)
Target price
33.05 USD
52-week range
13.36 – 30.46

Compare it with its sector

All 283 in Technology →
See the full ranking with filters →

Keep browsing the ranking

sorted by score, highest first

Frequently asked questions about Core Scientific

Is Core Scientific stock cheap or expensive?

On Price / sales, it trades 120% above the Technology median. Valuation score: 3.9 out of 10 (median for Technology: 5.3). Average analyst target: 33.05 USD, +107.3% versus the price. This is not investment advice.

What score does Core Scientific get on MeridIAn Screener?

It scores 4.8 out of 10, rank 1,778 of 2,130 (better than 16% of the companies analysed). Its strongest category is Growth (10.0) and its weakest, Risk & Context (0.3). Analysis of 08/10/2026.

How much is Core Scientific worth on the stock market?

Its market capitalisation is 5.1B USD and its enterprise value, debt included, is 7.8B USD.

How much debt does Core Scientific have?

Its net debt (debt minus cash) is 2.6B USD.

Does Core Scientific pay a dividend?

It pays no dividend, or almost none.

How has Core Scientific stock performed over the last year?

It has fallen 13.9% over the last year, excluding dividends. Over the last 52 weeks it has traded between 13.36 and 30.46 USD. Past performance does not guarantee future results.

What do analysts think of Core Scientific?

21 analysts cover it; their average recommendation is “Strong buy” and their average target is 33.05 USD (+107.3% versus the price). It is an estimate, not market data.